Coagulation management with factor concentrates in liver transplantation: A single-center experience

Transfusion

Volumn 54, Issue 1, 2014, Pages 2760-2768

  Kirchner, Carmen ^a   Dirkmann, Daniel ^a   Treckmann, Jürgen W ^a   Paul, Andreas ^a   Hartmann, Matthias ^a   Saner, Fuat H ^a   Görlinger, Klaus ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR; FIBRINOGEN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOPPLER FLOWMETRY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART MUSCLE ISCHEMIA; HEPATIC ARTERY THROMBOSIS; HUMAN; LIVER TRANSPLANTATION; LIVER VEIN THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PORTAL VEIN THROMBOSIS; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPH; THROMBOSIS; ALGORITHM; BLOOD COMPONENT THERAPY; ECHOGRAPHY; ISCHEMIA; LIVER DISEASES; MIDDLE AGED; MORTALITY; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; THROMBOELASTOGRAPHY; TRANSFUSION REACTION;

ADULT; ALGORITHMS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; FEMALE; FIBRINOGEN; HUMANS; ISCHEMIA; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBELASTOGRAPHY; THROMBOSIS; TRANSFUSION REACTION; ULTRASONOGRAPHY, DOPPLER;

EID: 84908473232     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12707     Document Type: Article

References (56)

1. Schlitt HJ, Loss M, Scherer MN, et al. [Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres]. Z Gastroenterol 2011; 49: 30-38.
2. Makroo RN, Walia RS, Aneja S, et al. Preoperative predictors of blood component transfusion in living donor liver transplantation. Asian J Transfus Sci 2013; 7: 140-146.
3. Lisman T, Porte RJ,. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116: 878-885.
4. Lisman T, Bakhtiari K, Pereboom IT, et al. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 2010; 52: 355-361.
5. Lisman T, Bongers TN, Adelmeijer J, et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006; 44: 53-61.
6. Tripodi A, Mannucci PM,. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365: 147-156.
7. Bismuth H, Castaing D, Ericzon BG, et al. Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet 1987; 2: 674-676.
8. de Boer MT, Christensen MC, Asmussen M, et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008; 106: 32-44, table of contents.
9. Pereboom IT, de Boer MT, Haagsma EB, et al. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 2009; 108: 1083-1091.
10. Tenza E, Bernardo CG, Escudero D, et al. Liver transplantation complications in the intensive care unit and at 6 months. Transplant Proc 2009; 41: 1050-1053.
11. Yildirim IO, Salihoglu Z, Bolayirli MI, et al. Prospective evaluation of the factors effective on morbidity and mortality of the patients having liver resection surgeries. Hepatogastroenterology 2012; 59: 1928-1932.
12. Planinsic RM, van der Meer J, Testa G, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 2005; 11: 895-900.
13. Levi M, Levy JH, Andersen HF, et al. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363: 1791-1800.
14. Gorlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179-1191.
15. Schochl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
16. Gorlinger K, Fries D, Dirkmann D, et al. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 2012; 39: 104-113.
17. Gorlinger K,. [Coagulation management during liver transplantation]. Hamostaseologie 2006; 26: S64-76.
18. Lorenz R, Kienast J, Otto U, et al. Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol 2003; 15: 15-20.
19. Scherer R, Gille A, Erhard J, et al. [The effect of substitution with AT III- and PPSB-concentrates in patients with terminal liver insufficiency]. Anaesthesist 1994; 43: 178-182.
20. Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114: 283-292.
21. Arshad F, Lisman T, Porte RJ,. Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient. Liver Int 2013; 33: 820-827.
22. Sakai T, Matsusaki T, Dai F, et al. Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictors. Br J Anaesth 2012; 108: 469-477.
23. Moreno-Gonzalez E, Meneu-Diaz JG, Fundora Y, et al. Advantages of the piggy back technique on intraoperative transfusion, fluid compsumption, and vasoactive drugs requirements in liver transplantation: a comparative study. Transplant Proc 2003; 35: 1918-1919.
24. Makris M, van Veen JJ, Maclean R,. Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient. J Thromb Thrombolysis 2010; 29: 171-181.
25. Sorensen B, Spahn DR, Innerhofer P, et al. Clinical review: prothrombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care 2011; 15: 201.
26. Hanke AA, Joch C, Görlinger K,. Long-term safety and efficacy of a pasteurised nan-ofiltrated prothrombin complex concentrate (Beriplex P/N). Br J Anaesth 2013; 110: 764-772.
27. Majeed A, Eelde A, Agren A, et al. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res 2012; 129: 146-151.
28. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-547.
29. Holland L, Warkentin TE, Refaai M, et al. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 2009; 49: 1171-1177.
30. Weinkove R, Rangarajan S,. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008; 18: 151-157.
31. Danes AF, Cuenca LG, Bueno SR, et al. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 2008; 94: 221-226.
32. Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41: 553-558.
33. Tripodi A, Primignani M, Chantarangkul V, et al. The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters. Thromb Res 2009; 124: 132-136.
34. Sabate A, Dalmau A, Koo M, et al. Coagulopathy management in liver transplantation. Transplant Proc 2012; 44: 1523-1525.
35. Blasi A, Beltran J, Pereira A, et al. An assessment of thromboelastometry to monitor blood coagulation and guide transfusion support in liver transplantation. Transfusion 2012; 52: 1989-1998.
36. Coakley M, Reddy K, Mackie I, et al. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006; 20: 548-553.
37. Roullet S, Pillot J, Freyburger G, et al. Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation. Br J Anaesth 2010; 104: 422-428.
38. Sibulesky L, Peiris P, Taner CB, et al. Intraoperative intracardiac thrombosis in a liver transplant patient. World J Hepatol 2010; 2: 198-200.
39. Schochl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15: R265.
40. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52.
41. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-273.
42. Karlsson M, Ternstrom L, Hyllner M, et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008; 48: 2152-2158.
43. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012; 119: 1757-1767.
44. Hellstern P,. Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma? Transfus Apher Sci 2008; 39: 69-74.
45. Hellstern P, Solheim BG,. The use of solvent/detergent treatment in pathogen reduction of plasma. Transfus Med Hemother 2011; 38: 65-70.
46. Freeman JW, Williamson LM, Llewelyn C, et al. A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation. Vox Sang 1998; 74 (Suppl 1): 225-229.
47. Williamson LM, Llewelyn CA, Fisher NC, et al. A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 1999; 39: 1227-1234.
48. Bartelmaos T, Chabanel A, Leger J, et al. Plasma transfusion in liver transplantation: a randomized, double-blind, multicenter clinical comparison of three virally secured plasmas. Transfusion 2013; 53: 1335-1345.
49. Bindi ML, Miccoli M, Marietta M, et al. Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: a prospective randomized control study. Vox Sang 2013; 105: 137-143.
50. Dara SI, Rana R, Afessa B, et al. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 2005; 33: 2667-2671.
51. Khan H, Belsher J, Yilmaz M, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007; 131: 1308-1314.
52. Sarani B, Dunkman WJ, Dean L, et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008; 36: 1114-1118.
53. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
54. Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240: 698-708; discussion 708-10.
55. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406; discussion 406-7.
56. Rana A, Petrowsky H, Hong JC, et al. Blood transfusion requirement during liver transplantation is an important risk factor for mortality. J Am Coll Surg 2013; 216: 902-907.